Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

ClinicalTrials.gov ID: NCT03971071

Public ClinicalTrials.gov record NCT03971071. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Chronic Migraine and Medication Overuse Headache

Study identification

NCT ID
NCT03971071
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Amgen
Industry
Enrollment
620 participants

Conditions and interventions

Interventions

  • Erenumab 70 mg Drug
  • Erenumab 140 mg Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 6, 2019
Primary completion
Nov 30, 2022
Completion
Jun 12, 2023
Last update posted
Sep 18, 2025

2019 – 2023

United States locations

U.S. sites
32
U.S. states
22
U.S. cities
31
Facility City State ZIP Site status
Core Healthcare Group Cerritos California 90703
Axiom Research Colton California 92324
Clinical Research Institute Los Angeles California 90048
The George Washington Medical Faculty Associates Washington D.C. District of Columbia 20037
University of Miami Miller School of Medicine Miami Florida 33136
Floridian Clinical Research LLC Miami Lakes Florida 33016
Clinical Neuroscience Solutions Orlando Florida 32801
Emerald Coast Center for Neurological Disorders Pensacola Florida 32504
University of South Florida Tampa Florida 33612
Saint Lukes Clinic Meridian Idaho 83642
Fort Wayne Neurological Center Fort Wayne Indiana 46804
College Park Family Care Center Overland Park Kansas 66212
Collective Medical Research Prairie Village Kansas 66208
University of Kentucky Lexington Kentucky 40536
DelRicht Research New Orleans Louisiana 70124
Neurology Center of New England PC Foxborough Massachusetts 02035
Michigan Head Pain and Neurological Institute Ann Arbor Michigan 48104
Clinical Research Institute Inc Minneapolis Minnesota 55402
Citizens Memorial Healthcare Bolivar Missouri 65613
Mercy Research St Louis Missouri 63141
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756
Dent Neurosciences Research Center Amherst New York 14226
Onsite Clinical Solutions LLC Charlotte North Carolina 28277
Clinical Trial Investigator Clinical Research Center Cincinnati Ohio 45212
Cleveland Clinic Cleveland Ohio 44195
Allegheny Health Network Cancer Institute at Mellon Pavilion Pittsburgh Pennsylvania 15224
Preferred Primary Care Physicians, Inc Pittsburgh Pennsylvania 15236
Nashville Neuroscience Group Nashville Tennessee 37203
Texas Neurology, PA Dallas Texas 75214
Wasatch Clinical Research LLC Salt Lake City Utah 84107
Marshall University Huntington West Virginia 25701
Aurora BayCare Medical Center Green Bay Wisconsin 54311

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03971071, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 18, 2025 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03971071 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →